LSM14B was correlated with purity (r = 0.189, p = 1.69 × 10−9) and CD4+ T-cell markers (r = 0.095, p = 3.15 × 10−3) (Figure 5) Eventually, through an HPA analysis, we observed a significant association between LSM4 expression in breast tumors and staining samples, while those of the remaining genes remained less clear, hence suggesting that aside from LSM4, those genes would have limited roles as prognostic biomarkers for BRCA. The gene discussed is CD4; the disease is breast neoplasm.